CBD Critical Cure is a modern, hybrid-indica variety derived from the genetics of Critical Kush. Cultivators can expect a flowering period of approximately 60 days for this strain, which is suitable for both indoor and outdoor cultivation environments. Characterized by a moderate level of grow difficulty, the plant is recognized for its ability to produce high yields.

The chemical profile of CBD Critical Cure is defined by a complex terpene arrangement, led by guaiol as the primary constituent, followed by caryophyllene and myrcene. This foundation is further nuanced by the presence of linalool, humulene, limonene, beta-pinene, pinene, nerolidol, camphene, and caryophyllene-oxide. These compounds interact to create a distinct sensory profile, distinguishing its aromatic and flavor characteristics through this specific hierarchy of volatile oils.

As a THC-dominant hybrid-indica, this strain is primarily sought for its capacity to induce a state of relaxation while maintaining a sense of focus. These effects make it a functional candidate for users addressing pain, stress, or sleep-related symptoms. At this time, there are no notable offspring recorded for this variety within the current registry.